Trial Profile
Post marketing study of sofosbuvir and ribavirin for hepatitis C virus genotype 2 infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jan 2019
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 23 Jan 2019 Status changed from active, no longer recruiting to completed.
- 23 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 22 Jul 2016 New trial record